The occupational environment has been a most fruitful one for investigating the etiology of human cancer. Many recognized human carcinogens are occupational carcinogens. There is a large volume of epidemiologic and experimental data concerning cancer risks in different work environments. It is important to synthesize this information for both scientific and public health purposes. Various organizations and individuals have published lists of occupational carcinogens. However, such lists have been limited by unclear criteria for which recognized carcinogens should be considered occupational carcinogens, and by inconsistent and incomplete information on the occupations and industries in which the carcinogenic substances may be found and on their target sites of cancer. Based largely on the evaluations published by the International Agency for Research on Cancer, and augmented with additional information, the present article represents an attempt to summarize, in tabular form, current knowledge on occupational carcinogens, the occupations and industries in which they are found, and their target organs. We have considered 28 agents as definite occupational carcinogens, 27 agents as probable occupational carcinogens, and 113 agents as possible occupational carcinogens. These tables should be useful for regulatory or preventive purposes and for scientific purposes in research priority setting and in understanding carcinogenesis.
Occupational carcinogens occupy a special place among the different classes of human carcinogens. The occupational environment has been a most fruitful one for investigating the etiology and pathogenesis of human cancer. Up to the 1970s, most recognized human carcinogens were substances or circumstances found primarily in the occupational environment, and although this may no longer be true with the growing list of recognized nonoccupational carcinogens, they still represent a large fraction of the total. Although it is important to discover occupational carcinogens for the sake of preventing occupational cancer, the potential benefit of such discoveries goes beyond the factory walls because most occupational exposures find their way into the general environment, sometimes at higher concentrations than in the workplace.
There is a large volume of epidemiologic and experimental data concerning cancer risks in different work environments. It is important to synthesize this information for both scientific and public health purposes. Various national and international bodies have published lists of carcinogens, but available lists of occupational carcinogens have been limited in various ways. Among the issues that are often missing, or treated rather casually, are a coherent assessment of which substances should be considered occupational carcinogens; information on the occupations and industries in which the carcinogenic substances may be found; and the target sites of cancer. The present article represents an attempt to summarize, in tabular form, current knowledge on occupational carcinogens, the occupations and industries in which they are found, and their target organs.
Methods and Results
Difficulties in listing occupational carcinogens. Although it seems like a simple enough task, it is very difficult to draw up an unambiguous list of occupational carcinogens. The first source of ambiguity concerns the definition of an "occupational" carcinogen. Most occupational exposures are also found in the general environment, and/or in consumer products; most general environmental exposures and consumer products, including medications, foods, and others, are found in some occupational environments. The distinctions can be quite arbitrary. For instance, although tobacco smoke, sunlight, and immunosuppressive medications are not primarily considered to be occupational exposures, there certainly are workers whose occupations bring them into contact with these agents. Also, although asbestos, benzene, and radon gas are considered to be occupational carcinogens, they are also found widely among the general population, and indeed, it is likely that many more people are exposed to these substances outside than inside the occupational environment. There is no simple rule to earmark occupational carcinogens as opposed to nonoccupational ones. Further, some carcinogens are chemicals that are used for research purposes and to which few people would ever be exposed, whether occupationally or nonoccupationally. Our operational criterion for designating occupational carcinogens is outlined below.
A second source of ambiguity derives from the rather idiosyncratic nature of the evidence. In some instances, we know that an occupational or industrial group is at excess risk of cancer, and we have a good idea of the causative agent; for example, scrotal cancer among chimney sweeps and polyaromatic hydrocarbons (PAHs) in soot (Waldron 1983) , and lung cancer among asbestos miners and asbestos fibers [International Agency for Research on Cancer (IARC) 1977] . In some instances, we know that a group experienced excess risk but the causative agent is unknown or at least unproven [e.g., lung cancer among painters (IARC 1989c) , bladder cancer among workers in the aluminum industry (IARC 1987) ]. The strength of the evidence for an association can vary. For some associations, the evidence of excess risk seems incontrovertible [e.g., liver angiosarcoma and vinyl chloride monomer (IARC 1979b) , bladder cancer and benzidine (IARC 1982b) ]. For some associations, the evidence is suggestive [e.g., lung cancer and diesel engine exhaust (IARC 1989a) , bladder cancer and employment as a painter (IARC 1989c) ]. Among the many substances in the industrial environment for which there are no human data concerning carcinogenicity, there are hundreds that have been shown to be carcinogenic in some animal species and thousands that have been shown to have some effect in assays of mutagenicity or genotoxicity. These considerations complicate the attempt to devise a list of occupational carcinogens.
IARC Monographs. For this task we drew on the authoritative IARC Monograph Program and its evaluation of carcinogenic risks to humans (IARC 1987 been operating since 1971, is to publish critical reviews of epidemiologic and experimental data on carcinogenicity for chemicals, groups of chemicals, industrial processes, other complex mixtures, physical agents, and biologic agents to which humans are known to be exposed, to evaluate the data in terms of human risk, and to indicate where additional research efforts are needed.
Substances are selected by IARC for evaluation on the basis of two main criteria: a) humans are exposed, and b) there is reason to suspect that the substance may be carcinogenic. Direct evidence concerning carcinogenicity of a substance can come from epidemiologic studies among humans or from experimental studies of animals (usually rodents). Additional evidence comes from the results of studies of chemical structure-activity analysis, absorption and metabolism, physiology, mutagenicity, cytotoxicology, and other aspects of toxicity. In the IARC Monographs, all types of data contribute to the evaluation.
In this article, we outline the IARC process because it is important to understand how decisions are made in order to properly interpret these decisions. IARC evaluations are carried out during specially convened meetings that typically last a week. The meetings may evaluate only one agent, such as silica, or they may address a set of related agents or even exposure circumstances such as an occupation or an industry. For each such meeting, and there have typically been three per year, IARC convenes an international working group, usually involving from 15 to 30 experts on the topic(s) being evaluated, from four perspectives, a) exposure and occurrence of the substances being evaluated, b) human evidence of cancer risk (i.e., epidemiology), c) animal carcinogenesis, and d) other data relevant to the evaluation of carcinogenicity and its mechanisms. The working group is asked to review all of the literature relevant to an assessment of carcinogenicity. In the first part of the meeting, four subgroups (based on the four perspectives mentioned above) review and revise drafts prepared by members of the subgroup, and each subgroup develops a joint review and evaluation of the evidence on which they have focused. Subsequently, the entire working group convenes in plenary and proceeds to derive a joint text. They determine whether the epidemiologic evidence supports the hypothesis that the substance causes cancer, and, separately, whether the animal evidence supports the hypothesis that the substance causes cancer. The judgments are not simply dichotomous (yes/no), but rather they allow the working group to express a range of opinions on each of the dimensions evaluated. Table 1 shows the categories into which the working groups are asked to classify each substance, when examining only the epidemiologic evidence and when examining only the animal experimental evidence. The operational criteria for making these decisions leave room for interpretation, and the scientific evidence itself is open to interpretation. It is not surprising, then, that the evaluations are sometimes difficult and contentious.
The overall evaluation of human carcinogenicity is based on the epidemiologic and animal evidence of carcinogenicity, plus any other relevant evidence on genotoxicity, mutagenicity, metabolism, or mechanisms. Epidemiologic evidence, where it exists, is given greatest weight. Direct animal evidence of carcinogenicity is next in importance, with increasing attention paid to mechanistic evidence that can inform the relevance of the animal evidence for human risk assessment. Table 2 shows the categories for the overall evaluation and how they are derived from human, animal, and other evidence. Each substance is classified into one of the following groups: carcinogenic (group 1), probably carcinogenic (group 2A), possibly carcinogenic (group 2B), not classifiable (group 3), probably not carcinogenic (group 4). However, the algorithm implied by Table 2 is only indicative, and the working group may derive an overall evaluation that departs from the strict interpretation of the algorithm. For example, neutrons have been classified as human carcinogens (group 1) despite the absence of epidemiologic data, because of overwhelming experimental evidence and mechanistic considerations (IARC 2000a) . The IARC process relies on consensus, and this is usually achieved, but sometimes differing opinions among experts lead to split decisions. In the end, the published evaluations reflect the views of at least a majority of participating experts. The results of IARC evaluations are published in readily available and user-friendly volumes, and summaries are published on the IARC website (IARC 2003) .
For our purpose, there are several limitations to bear in mind. First, IARC does not provide any explicit indication as to whether the substance evaluated should be considered an occupational exposure. Second, although the working groups certainly study the evidence in relation to cancer sites, until recently the formal evaluations did not identify which sites of cancer may be at risk. Site-specific information needs to be gleaned from the working group's report and other literature. Third, the evaluations are anchored in the Review | Siemiatycki et al. 1448 VOLUME 112 | NUMBER 15 | November 2004 • Environmental Health Perspectives Table 1 . Classifications used in the IARC Monographs to characterize evidence of carcinogenicity.
Category of evidence
In humans In animals Sufficient evidence of A causal relationship has been established between exposure to A causal relationship has been established between the agent or carcinogenicity the agent, mixture, or exposure circumstances and human cancer. mixture and an increased incidence of malignant neoplasms or of That is, a positive relationship has been observed between the an appropriate combination of benign and malignant neoplasms in exposure and cancer in studies in which chance, bias, and a) two or more species of animals or b) in two or more independent confounding could be ruled out with reasonable confidence. studies in one species carried out at different times or in different laboratories or under different protocols. Limited evidence of A positive association has been observed between exposure to the The data suggest a carcinogenic effect but are limited for making a carcinogenicity agent, mixture, or exposure circumstance and cancer for which definitive evaluation because, for example, a) the evidence of a causal interpretation is considered to be credible, but chance, bias, carcinogenicity is restricted to a single experiment; b) there are or confounding could not be ruled out with reasonable confidence.
unresolved questions regarding the adequacy of the design, conduct, or interpretation of the study; or c) the agent or mixture increases the incidence only of benign neoplasms or lesions of uncertain neoplastic potential, or of certain neoplasms that may occur spontaneously in high incidences in certain strains. (IARC 2003) . We reviewed each one and earmarked those that we consider to be "occupational exposures."
In developing a decision rule, we considered the following dimensions: whether the evidence of an effect drew on studies in exposed workers, whether the agent was found more often in the occupational or nonoccupational environments, and the numbers of workers exposed. In the end, the first two dimensions became redundant when we applied the third. Thus, a substance was considered an occupational exposure if there are, or have been, significant numbers of workers exposed to the substance at significant levels. The fact that some workers were exposed to a substance was not enough to label it as an occupational carcinogen. There are many carcinogens to which few workers are exposed, and we did not want to dilute the lists with such obscure agents.
Unfortunately, the knowledge base for determining how many workers are or have been exposed, and at what levels, is very fragmentary. We relied on available documentation such as the IARC Monographs, surveys by the National Institute for Occupational Safety and Health (NIOSH 1990) , the National Toxicology Program (NTP) Report on Carcinogens, Tenth Edition (NTP 2002) , and informed guesses on the part of expert industrial hygienists. Where we could come up with approximate numbers of workers exposed, we had to have some type of operational threshold for what should be considered a significant number. As a rule of thumb, we used > 10,000 workers exposed worldwide or > 1,000 in any country, presently or at any time in the past. These were the guidelines against which we measured our imprecise and semisubjective estimates. We also had to operationalize the notion of a level of exposure that was significant. This was even less explicit than the criteria used for numbers of workers exposed; it depended, inter alia, on the known range of exposure levels to the agent.
Despite the fact that they may be found in occupational environments, some classes of agents were summarily excluded from consideration on the grounds that the exposures are rare or very infrequent or at very low doses. These included hormones, pharmaceuticals, microbiologic agents, and dietary constituents. Pharmaceuticals represent a special case. Many have been evaluated, and many are considered to be carcinogenic. Although the main population exposed consists of patients undergoing therapy, there can also be exposure of workers who produce the drugs and of health care workers who administer them. But because the exposure doses are orders of magnitude higher among patients than among workers, we have not listed these as occupational carcinogens. Analogously, we have not listed carcinogenic viruses, notably, human immunodeficiency virus (HIV) and hepatitis B and C viruses, although health care workers may be at risk.
With these criteria, we derived the following lists of occupational carcinogens:
• 28 definite human occupational carcinogens (IARC group 1; As discussed above, the evaluations are rooted in the information base that was available at the time of the IARC evaluation. As evidence accumulates, the evaluation of an agent can change, as has already occurred in some cases (e.g., cadmium, acrylonitrile). This is why we have included in the tables a reference to the IARC volume in which the substance was evaluated and its date. Evaluations with early dates are more vulnerable to being out of date.
In a special review published in 1987 (Supplement 7), all substances and occupations covered in the first 15 years of the program were reevaluated (IARC 1987 For the agents in Tables 3-5 , we devised a set of subheadings to help the reader digest the long lists of often obscure chemical names: physical agents, respirable dusts and fibers, metals and metal compounds, PAHs, wood and fossil fuels and their by-products, monomers, intermediates in plastics and rubber manufacturing, chlorinated hydrocarbons, aromatic amine dyes, azo dyes, intermediates in the production of dyes, pesticides, nitro compounds, and others. Tables 3-5 indicate some of the main occupations or industries in which each listed substance is found, and the strength of evidence from human and animal studies. In Tables 3 and 4 , we show the type(s) of cancer affected, with an indication of the strength of evidence for each type listed. Information on target organ is not shown in Table 5 because, for agents listed as possible carcinogens, evidence concerning humans is either conflicting or not available at all.
For many of the agents listed, but not all, there has been some epidemiologic evidence of carcinogenicity among exposed workers. For most of the agents listed, but not all, the occupational environment represents the most common locale of exposure. The most prominent exceptions to this rule are aflatoxins, sunlight, involuntary tobacco smoking, and radon. Whether these cause more cases of cancer as a result of occupational or nonoccupational exposure depends on numbers exposed and exposure levels in the two types of milieu. It is plausible that there may be more cases resulting from nonoccupational exposure.
The aims at a systematic evaluation of agents and complex mixtures, it is not intended to provide a systematic review of cancer risk by industries and occupations. That is, those reviews were conducted where there were particular concerns or anticipated insights regarding specific potential carcinogens. Sometimes this was done when there appeared to be strong evidence of risk in an occupation but little indication of what the responsible agent might be (e.g., rubber industry, painters). Sometimes the impetus for an occupation or industry review came from the attempt to evaluate some agent, but it was realized that the evidence regarding that agent was rooted in epidemiologic evidence regarding some occupation or industry (e.g., glass industry, hairdresser). Table 6 shows those occupations and industries that IARC has evaluated as definitely, probably, or possibly entailing a carcinogenic risk. Because there has been no pretense of exhaustiveness in evaluating occupations and industries, the absence of an occupation or industry in Table 6 does not carry the same significance as the absence of an agent in Tables 3-5 . That is, it does not signify that there is no known risk for that occupation or industry. Because our inclusion criteria admitted substances to which workers were exposed in the past, we included some substances that have been banned or virtually eliminated in some countries, such as mustard gas, bis(chloromethyl) ether, tris(2,3-dibromopropyl) phosphate, and 4,4´-methylene bis(2-chloroaniline) (MOCA), as well as some industries that no longer exist (viz., production of auramine and magenta). These are mentioned partly for historic interest and partly because it is possible that these might yet be used in some places at some time.
It is important to note that the substances, occupations, and industries listed in Tables 3-6 are not mutually exclusive. Certainly, some of the occupations and industries listed in Table 6 may be there because of some of the substances that are listed in Tables 3-5 . But further, the substances relate to each other in complicated ways. Some families of substances include some specific substances that are also listed (e.g., nonarsenical insecticides, which includes DDT; benzidinebased dyes, which includes benzidine). Also, there are some complex mixtures (e.g., diesel a Not necessarily an exhaustive list of occupations/industries in which this agent is found; not all workers in these occupations/industries are exposed. The term "production" is used to indicate that this substance is man-made and that workers may be exposed in the production process. b Most recent IARC evaluation; for those referenced to Supplement 7 (IARC 1987) , it is possible that the 1987 review was quite perfunctory and that the essential evidence was cumulated at an earlier date. c As judged by the IARC working group; we added the notation "not available" to signify those substances for which there was no evidence at all. d We judged that evidence for an association with this site was strong. e We judged that evidence was suggestive. exhaust) that contain a substance on the list (e.g., nitro-PAHs) that may be responsible for the carcinogenicity of the mixture. The listing of affected cancer sites in Tables 3 and 4 does not come explicitly from the IARC Monographs. Sometimes the affected target organ(s) was rather evident, but sometimes it required that we evaluate the evidence, including evidence published more recently than the IARC evaluation in question. Table 7 shows the same agents listed in Tables 3 and 4 but organized by site of cancer. Again, we indicate clearly which associations are strong and which are only suggestive. The lung is the target organ that has most often been linked to occupational carcinogens.
The evolution of knowledge. In order to appreciate how knowledge has evolved, we searched for information on the current occupational carcinogens at two earlier time periods. As mentioned above, IARC carried out a comprehensive cumulative synthesis in 1987 (IARC 1987) . In that report, the results were presented with the same rating system (group 1, 2A, 2B, 3) as is used today, rendering the lists comparable. In 1964, even before the establishment of IARC, the World Health Organization (WHO) commissioned an expert panel to survey available knowledge on human carcinogens (WHO 1964) . In the WHO report, there was no explicit rating system. It was a discursive presentation of knowledge and opinions that we attempted, with some license, to translate into a simple system corresponding to definite, probable/possible, or not mentioned. From these two reports, we searched for references to the 168 substances presented in Tables 3-5 and that are currently considered to be definite, probable, or possible occupational carcinogens. 
Discussion
Many of the recognized definite occupational carcinogens were first suspected before the era of modern epidemiology (i.e., before 1950). The significance of this observation is unclear. It may be that there were only a limited number of strong occupation-cancer associations, and these were sufficiently obvious that they could produce observable clusters of cases for astute clinicians to notice. It may be that levels of exposure to occupational chemicals were so high before the 1950s as to produce high cancer risks and cancer clusters, but that improvements in industrial hygiene in industrialized countries have indeed decreased risks to levels that are difficult to detect. The number of occupational agents rated by IARC as group 1 carcinogens has tapered off since 1987, whereas the proportion of group 2B evaluations has increased. This reflects the fact that, when the monograph program began, there was a "backlog" of agents for which strong evidence of carcinogenicity had accumulated, and, naturally, these were the agents that IARC initially selected for review. Once the agents with strong evidence had been dealt with, IARC started dealing with others. It would be wrong to infer that the historic trend in IARC designations signals that we are approaching the end of the period of potential to discover occupational carcinogens. There are many thousands of chemicals in workplaces, and new ones are continuously being introduced. Most recognized occupational carcinogens were first suspected on the basis of case reports by clinicians or pathologists (Doll 1975) . These discoveries were usually coincidental (Siemiatycki et al. 1981 Production; used in the textile phosphate industry; Vol. 71 (1999a) Inadequate Sufficient in phenolic resins (for electronics industry), paints, paper coatings, and rubber CNS, central nervous system. a Not necessarily an exhaustive list of occupations/industries in which this agent is found; not all workers in these occupations/industries are exposed. The term "production" is used to indicate that this substance is man-made and that workers may be exposed in the production process. b Most recent IARC evaluation; for those referenced as Supplement 7 (IARC 1987) , it is possible that the 1987 review was quite perfunctory and that the essential evidence was cumulated at an earlier date. c As judged by the IARC working group; we added the notation "not available" to signify those substances for which there was no epidemiologic evidence at all. d We judged that the evidence was suggestive. a Not necessarily an exhaustive list of occupations/industries in which this agent is found; not all workers in these occupations/industries are exposed. The term "production" is used to indicate that this substance is man-made and that workers may be exposed in the production process. b Most recent IARC evaluation; for those referenced as Supplement 7 (IARC 1987) , it is possible that the 1987 review was quite perfunctory and that the essential evidence was cumulated at an earlier date. c As judged by the IARC working group; we added the notation "not available" to signify those substances for which there was no epidemiologic evidence at all. (NTP 2002) . This list uses a two-category scale: "known to be a human carcinogen" and "reasonably anticipated to be a human carcinogen." Currently, there are 52 agents listed in the first category and 176 in the second. Information concerning each agent is described in a brief report that includes some exposure data as well as health effects data and regulatory data (NTP 2002) . The substances on these lists are not limited to occupational agents, and there is no tabular summary of occupational agents, the occupations in which these may occur, or the target organs. It is beyond the scope of this article to carry out a comparison of the procedures and lists of the various national bodies. Suffice it to say that most of them draw heavily on the IARC program and adapt it to their purposes. There is sometimes a tendency to interpret tables of carcinogens in too categorical a fashion. Although it may be convenient for lobbyists and regulators to divide the world of chemicals and occupational circumstances into "good guys" and "bad guys," such a dichotomy is simplistic. The determination that a substance or circumstance is carcinogenic depends on the strength of evidence at a given point in time. The evidence is sometimes clear-cut (which would correspond to evaluations of group 1 or group 4), but more often it is not. The balance of evidence can change in either direction as new data emerge.
The characterization of an occupation or industry group as a "high-risk group" is strongly rooted in time and place. For instance, the fact that some groups of nickel refinery workers experienced excess risks of nasal cancer does not imply that all workers in all nickel refineries will be subject to such risks. The particular circumstances of the industrial process, raw materials, impurities, and control measures may produce risk in one nickel refinery but not in another or in one historic era but not in another. The same can be said of rubber production facilities, aluminum refineries, and other industries and occupations. Labeling a chemical substance as a carcinogen in humans is a more timeless statement than labeling an occupation or industry as a high-risk group. However, even such a statement requires qualification. Different carcinogens produce different levels of risk, and for a given carcinogen there may be vast differences in the risks incurred by different people exposed under different circumstances. Indeed, there may be threshold effects or interactions with other factors, environmental or genetic, that produce no risk for some exposed workers and high risk for others.
This raises the issue of quantitative risk assessment, which is an important tool in prevention of occupational cancer. Unfortunately, our tables provide no basis for gauging the strength of the effect of each carcinogen, either in relative risk terms or in absolute risk terms, or in terms of dose-response relationships. The IARC evaluations provide no such indications, and although it would be most desirable to have such information, for most agents the information base to support such quantification is fragmentary.
In summary, the listing of occupational carcinogens is important. It provides a yardstick of our knowledge base, it provides guidance in setting research priorities, and it provides an important tool for prevention of cancer. Regulatory procedures and other aspects of cancer prevention depend on the listing of carcinogens. The IARC Monograph Program has been an indispensable component of this process. The tables presented herein, based on IARC Monographs but augmented in various ways, will be useful to researchers in setting research priorities and in furthering our understanding of carcinogenesis, and to those interested in preventing occupational cancer.
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